Trexquant Investment LP Day One Biopharmaceuticals, Inc. Transaction History
Trexquant Investment LP
- $8.01 Billion
- Q1 2025
A detailed history of Trexquant Investment LP transactions in Day One Biopharmaceuticals, Inc. stock. As of the latest transaction made, Trexquant Investment LP holds 204,782 shares of DAWN stock, worth $1.36 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
204,782
Previous 87,972
132.78%
Holding current value
$1.36 Million
Previous $1.11 Million
45.69%
% of portfolio
0.02%
Previous 0.01%
Shares
4 transactions
Others Institutions Holding DAWN
# of Institutions
196Shares Held
76.7MCall Options Held
138KPut Options Held
208K-
Atlas Venture Life Science Advisors, LLC6.43MShares$42.7 Million14.93% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.94MShares$39.5 Million0.0% of portfolio
-
Ra Capital Management, L.P. Boston, MA5.76MShares$38.2 Million0.95% of portfolio
-
Black Rock Inc. New York, NY4.53MShares$30.1 Million0.0% of portfolio
-
Alyeska Investment Group, L.P. Chicago, IL4.06MShares$27 Million0.14% of portfolio
About Day One Biopharmaceuticals, Inc.
- Ticker DAWN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 73,461,104
- Market Cap $488M
- Description
- Day One Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops and commercializes targeted therapies for patients with genetically defined cancers. Its lead product candidate is DAY101, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric pa...